United States
Germany
Japan
United Kingdom
China
KCTD14 (myc-DDK-tagged) - Human potassium channel tetramerization domain containing 14 (KCTD14), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
Kctd14 (tGFP-tagged) - Mouse potassium channel tetramerisation domain containing 14 (Kctd14)
| Type | Mouse Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Kctd14 (myc-DDK-tagged) - Mouse potassium channel tetramerisation domain containing 14 (Kctd14), transcript variant 2
| Type | Mouse Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Carrier-free (BSA/glycerol-free) KCTD14 mouse monoclonal antibody, clone OTI2E9 (formerly 2E9)
| Applications | WB |
| Reactivities | Human |
KCTD14 mouse monoclonal antibody, clone OTI2B9 (formerly 2B9)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
KCTD14 mouse monoclonal antibody,clone 2E9, Biotinylated
| Applications | WB |
| Reactivities | Human |
KCTD14 mouse monoclonal antibody,clone 2E9, HRP conjugated
| Applications | WB |
| Reactivities | Human |
KCTD14 mouse monoclonal antibody, clone OTI3A4 (formerly 3A4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
KCTD14 mouse monoclonal antibody, clone OTI3F5 (formerly 3F5)
| Applications | FC, IF, WB |
| Reactivities | Human |
Lenti ORF clone of Kctd14 (Myc-DDK-tagged) - Mouse potassium channel tetramerisation domain containing 14 (Kctd14), transcript variant 3
| Type | Mouse Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
Lenti ORF clone of Kctd14 (mGFP-tagged) - Mouse potassium channel tetramerisation domain containing 14 (Kctd14), transcript variant 3
| Type | Mouse Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human potassium channel tetramerisation domain containing 14 (KCTD14), mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
